Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators

被引:272
作者
Corton, JC [1 ]
Anderson, SP [1 ]
Stauber, A [1 ]
机构
[1] Chem Ind Inst Toxicol, Res Triangle Pk, NC 27709 USA
关键词
hepatocarcinogenesis; inflammation; growth suppression;
D O I
10.1146/annurev.pharmtox.40.1.491
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peroxisome proliferators (PPs) are a large class of structurally dissimilar chemicals that have diverse effects in rodents and humans. Most, if not all, of the diverse effects of PPs are mediated by three members of the nuclear receptor superfamily called peroxisome proliferator-activated receptors (PPARs). In this review, we define the molecular mechanisms of PPs, including PPAR binding specificity, alteration of gene expression through binding to DNA response elements, and cross talk with other signaling pathways. We discuss the roles of PPARs in growth promotion in rodent hepatocarcinogenesis and potential therapeutic effects, including suppression of cancer growth and inflammation.
引用
收藏
页码:491 / 518
页数:28
相关论文
共 141 条
  • [1] Anderson SP, 1999, MOL CARCINOGEN, V26, P226, DOI 10.1002/(SICI)1098-2744(199912)26:4<226::AID-MC2>3.0.CO
  • [2] 2-Q
  • [3] MECHANISTICALLY-BASED HUMAN HAZARD ASSESSMENT OF PEROXISOME PROLIFERATOR-INDUCED HEPATOCARCINOGENESIS
    ASHBY, J
    BRADY, A
    ELCOMBE, CR
    ELLIOTT, BM
    ISHMAEL, J
    ODUM, J
    TUGWOOD, JD
    KETTLE, S
    PURCHASE, IFH
    [J]. HUMAN & EXPERIMENTAL TOXICOLOGY, 1994, 13 : S1 - S117
  • [4] COMPARISON OF THE ACUTE AND CHRONIC MITOGENIC EFFECTS OF THE PEROXISOME PROLIFERATORS METHYLCLOFENAPATE AND CLOFIBRIC ACID IN RAT-LIVER
    BARRASS, NC
    PRICE, RJ
    LAKE, BG
    ORTON, TC
    [J]. CARCINOGENESIS, 1993, 14 (07) : 1451 - 1456
  • [5] MECHANISMS OF MULTISTEP CARCINOGENESIS AND CARCINOGEN RISK ASSESSMENT
    BARRETT, JC
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1993, 100 : 9 - 20
  • [6] SUPPRESSION OF LIVER-CELL APOPTOSIS IN-VITRO BY THE NONGENOTOXIC HEPATOCARCINOGEN AND PEROXISOME PROLIFERATOR NAFENOPIN
    BAYLY, AC
    ROBERTS, RA
    DIVE, C
    [J]. JOURNAL OF CELL BIOLOGY, 1994, 125 (01) : 197 - 203
  • [7] Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects
    Berger, J
    Leibowitz, MD
    Doebber, TW
    Elbrecht, A
    Zhang, B
    Zhou, GC
    Biswas, C
    Cullinan, CA
    Hayes, NS
    Li, Y
    Tanen, M
    Ventre, J
    Wu, MS
    Berger, GD
    Mosley, R
    Marquis, R
    Santini, C
    Sahoo, SP
    Tolman, RL
    Smith, RG
    Moller, DE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) : 6718 - 6725
  • [8] CONTROLLED DEATH (APOPTOSIS) OF NORMAL AND PUTATIVE PRENEOPLASTIC CELLS IN RAT-LIVER FOLLOWING WITHDRAWAL OF TUMOR PROMOTERS
    BURSCH, W
    LAUER, B
    TIMMERMANNTROSIENER, I
    BARTHEL, G
    SCHUPPLER, J
    SCHULTEHERMANN, R
    [J]. CARCINOGENESIS, 1984, 5 (04) : 453 - 458
  • [9] Peroxisome proliferators induce apoptosis in hepatoma cells
    Canuto, RA
    Muzio, G
    Bonelli, G
    Maggiora, M
    Autelli, R
    Barbiero, G
    Costelli, P
    Brossa, O
    Baccino, FM
    [J]. CANCER DETECTION AND PREVENTION, 1998, 22 (04): : 357 - 366
  • [10] An adipogenic cofactor bound by the differentiation domain of PPARγ
    Castillo, G
    Brun, RP
    Rosenfield, JK
    Hauser, S
    Park, CW
    Troy, AE
    Wright, ME
    Spiegelman, BM
    [J]. EMBO JOURNAL, 1999, 18 (13) : 3676 - 3687